Acuren [TIC] vs Cimpress plc [CMPR] Detailed Stock Comparison
Acuren
NYSE
Loading...
Cimpress plc
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Acuren wins in 3 metrics, Cimpress plc wins in 13 metrics, with 0 ties. Cimpress plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Acuren | Cimpress plc | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 44.48 | 9.50 | Cimpress plc |
| Price-to-Book Ratio | 1.02 | N/A | N/A |
| Debt-to-Equity Ratio | 71.71 | -3.12 | Cimpress plc |
| PEG Ratio | -0.08 | 9.83 | Acuren |
| EV/EBITDA | 24.97 | 7.55 | Cimpress plc |
| Profit Margin (TTM) | -13.14% | 0.44% | Cimpress plc |
| Operating Margin (TTM) | -3.75% | 8.08% | Cimpress plc |
| EBITDA Margin (TTM) | N/A | 8.08% | N/A |
| Return on Equity | -19.28% | -32.99% | Acuren |
| Return on Assets (TTM) | -1.04% | 7.51% | Cimpress plc |
| Free Cash Flow (TTM) | $73.67M | $237.49M | Cimpress plc |
| 1-Year Return | -25.63% | -33.17% | Acuren |
| Price-to-Sales Ratio (TTM) | 1.68 | 0.40 | Cimpress plc |
| Enterprise Value | $1.84B | $2.81B | Cimpress plc |
| EV/Revenue Ratio | 1.66 | 0.83 | Cimpress plc |
| Gross Profit Margin (TTM) | 18.64% | 47.18% | Cimpress plc |
| Revenue per Share (TTM) | $13 | $137 | Cimpress plc |
| Earnings per Share (Diluted) | $-1.25 | $5.83 | Cimpress plc |
| Beta (Stock Volatility) | N/A | 1.70 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Acuren vs Cimpress plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Acuren | -3.50% | -15.05% | -17.44% | -9.56% | -21.92% | -21.92% |
| Cimpress plc | -0.22% | 4.08% | 15.84% | 30.69% | -0.50% | -20.99% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Acuren | -25.63% | -25.63% | 240.73% | -99.93% | -99.88% | -99.88% |
| Cimpress plc | -33.17% | 25.59% | -41.92% | -21.45% | 89.52% | 263.02% |
Performance & Financial Health Analysis: Acuren vs Cimpress plc
| Metric | TIC | CMPR |
|---|---|---|
| Market Information | ||
| Market Cap | $1.86B | $1.36B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 4,317,010 | 334,540 |
| 90 Day Avg. Volume | 2,700,947 | 308,060 |
| Last Close | $9.37 | $55.36 |
| 52 Week Range | $8.76 - $14.28 | $35.21 - $102.22 |
| % from 52W High | -34.38% | -45.84% |
| All-Time High | $14,700.00 (Jul 03, 2017) | $171.76 (Mar 05, 2018) |
| % from All-Time High | -99.94% | -67.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.04% |
| Quarterly Earnings Growth | N/A | 0.01% |
| Financial Health | ||
| Profit Margin (TTM) | -0.13% | 0.00% |
| Operating Margin (TTM) | -0.04% | 0.08% |
| Return on Equity (TTM) | -0.19% | -0.33% |
| Debt to Equity (MRQ) | 71.71 | -3.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.22 | $-23.84 |
| Cash per Share (MRQ) | $1.27 | $9.56 |
| Operating Cash Flow (TTM) | $34.94M | $298.07M |
| Levered Free Cash Flow (TTM) | $172.22M | $204.82M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Acuren vs Cimpress plc
| Metric | TIC | CMPR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 44.48 | 9.50 |
| Forward P/E | 30.14 | 9.83 |
| PEG Ratio | -0.08 | 9.83 |
| Price to Sales (TTM) | 1.68 | 0.40 |
| Price to Book (MRQ) | 1.02 | N/A |
| Market Capitalization | ||
| Market Capitalization | $1.86B | $1.36B |
| Enterprise Value | $1.84B | $2.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.66 | 0.83 |
| Enterprise to EBITDA | 24.97 | 7.55 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.70 |
| Book Value per Share (MRQ) | $9.22 | $-23.84 |
Financial Statements Comparison: Acuren vs Cimpress plc
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TIC | CMPR |
|---|---|---|
| Revenue/Sales | $234.22M | $789.47M |
| Cost of Goods Sold | $190.55M | $416.96M |
| Gross Profit | $43.67M | $372.51M |
| Research & Development | N/A | $83.11M |
| Operating Income (EBIT) | $-8.79M | $41.01M |
| EBITDA | $20.93M | $75.38M |
| Pre-Tax Income | $-24.33M | $4.12M |
| Income Tax | $1.47M | $12.14M |
| Net Income (Profit) | $-25.79M | $-8.02M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TIC | CMPR |
|---|---|---|
| Cash & Equivalents | $155.74M | $183.00M |
| Total Current Assets | $376.67M | $443.71M |
| Total Current Liabilities | $107.93M | $679.70M |
| Long-Term Debt | $784.25M | $1.66B |
| Total Shareholders Equity | $1.13B | $-536.71M |
| Retained Earnings | $-132.78M | $266.18M |
| Property, Plant & Equipment | $30.52M | $365.07M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TIC | CMPR |
|---|---|---|
| Operating Cash Flow | $35.09M | $1.04M |
| Capital Expenditures | $-4.18M | $-24.79M |
| Free Cash Flow | $28.32M | $-31.44M |
| Debt Repayment | $-4.44M | $-6.25M |
| Common Stock Repurchase | N/A | $-3.95M |
Short Interest & Institutional Ownership Analysis
| Metric | TIC | CMPR |
|---|---|---|
| Shares Short | 8.45M | 1.97M |
| Short Ratio | 3.54 | 5.98 |
| Short % of Float | 0.16% | 0.15% |
| Average Daily Volume (10 Day) | 4,317,010 | 334,540 |
| Average Daily Volume (90 Day) | 2,700,947 | 308,060 |
| Shares Outstanding | 121.48M | 25.08M |
| Float Shares | 44.17M | 14.30M |
| % Held by Insiders | 0.10% | 0.16% |
| % Held by Institutions | 0.51% | 0.83% |
Dividend Analysis & Yield Comparison: Acuren vs Cimpress plc
| Metric | TIC | CMPR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |